Reflection on modern methods: a common error in the segmented regression parameterization of interrupted time-series analyses
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Interrupted time-series (ITS) designs are a robust and increasingly popular non-randomized study design for strong causal inference in the evaluation of public health interventions. One of the most common techniques for model parameterization in the analysis of ITS designs is segmented regression, which uses a series of indicators and linear terms to represent the level and trend of the time-series before and after an intervention. In this article, we highlight an important error often presented in tutorials and published peer-reviewed papers using segmented regression parameterization for the analyses of ITS designs. We show that researchers cannot simply use the product between their calendar time variable and the indicator variable indicating pre- versus post-intervention time periods to represent the post-intervention linear segment. If researchers use this often-presented parameterization, they will get an erroneous result for the level change in their time-series. We show that researchers must take care to use the product between their intervention variable and the time elapsed since the start of the intervention, rather than the time since the beginning of their study. Thus, the second linear segment of the time-series indexing the post-intervention level and trend should be zero before intervention implementation and begin by counting from zero, rather than counting from the time elapsed since the beginning of the study. We hope that this article can clarify segmented regression parameterization for the analysis of ITS designs and help researchers avoid confusing and erroneous results in the level changes of their time-series.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Segmented regression analysis of interrupted time series studies in medication use research
Wagner, A. K., Soumerai, S. B., Zhang, F., & Ross-Degnan, D. (2002) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1046/j.1365-2710.2002.00430.x · Cited by 3,279
Interrupted time series regression for the evaluation of public health interventions: a tutorial
Lopez Bernal, J., Cummins, S., & Gasparrini, A. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw098 · Cited by 3,049
Conducting Interrupted Time-series Analysis for Single- and Multiple-group Comparisons
Linden, A. (2015) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x1501500208 · Cited by 1,233
Use of Interrupted Time Series Analysis in Evaluating Health Care Quality Improvements
Penfold, R. B., & Zhang, F. (2013) · Academic Pediatrics · doi:10.1016/j.acap.2013.08.002 · Cited by 1,150
Ramsay, C. R., Matowe, L., Grilli, R., Grimshaw, J. M., & Thomas, R. E. (2003) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462303000576 · Cited by 703
Stallings-Smith, S., Zeka, A., Goodman, P., Kabir, Z., & Clancy, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062063 · Cited by 99
Cited by
Sulis, G., Batomen, B., Kotwani, A., Pai, M., & Gandra, S. (2021) · PLoS Medicine · doi:10.1371/journal.pmed.1003682 · Cited by 117
“Next we conducted segmented regression analyses of time series data to assess how much the epidemic onset affected monthly sales volumes of (1) all antibiotics (including azithromycin), (2) azithromycin only (categorized as Schedule H), and (3) HCQ (categorized as Schedule H1 since March 2020) [35,42].”
Zhang, Y., Ren, Y., Huang, Y., Yao, M., Jia, Y., Wang, Y., Mei, F., Zou, K., Tan, J., & Sun, X. (2024) · BMC Medical Research Methodology · doi:10.1186/s12874-024-02184-8 · Cited by 7
(2024) · doi:10.2196/50407 · Cited by 7
Self-citation
Metadata
- Authors
- Xiao, H., Augusto, O., & Wagenaar, B. H.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-10-23
- Volume
- 50
- Issue
- 3
- Pages
- 1011-1015
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W3093871853
- Cited by
- 102
- References
- 6
- FWCI
- 8.64
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.